Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T Cell Receptors Associated with Crohn’s Disease
Science in Seattle,
Adaptive Biotechnologies, a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune…